miRNA News
Most Popular miRNA Story
Researchers fingerprint head, neck cancer for better diagnostics
Aggressive cancer treatment can be associated with a lot of side effects, but is often essential if the cancer is going to be life-threatening. Knowing how fast a cancer will progress is therefore Read more...
Latest Headlines
Researchers fingerprint head, neck cancer for better diagnostics
Aggressive cancer treatment can be associated with a lot of side effects, but is often essential if the cancer is going to be life-threatening. Knowing how fast a cancer will progress is therefore Read more...
Blood miRNAs can affect cancer biomarker studies
Short strands of genetic material called MicroRNAs (miRNAs) are being studied more and more as potential biomarkers. However, U.S. researchers may have found a hitch--or certainly a caution--in this Read more...
Biomarkers could help with pancreatic cancer watchful waiting
Pancreatic cysts are generally benign and asymptomatic, and physicians just keep an eye on them--known as watchful waiting. However, some forms of pancreatic cysts, such as intraductal papillary Read more...
Nano-sensor zeros in on lung cancer marker
Some biomarkers lack technologies to precisely detect them for medical applications. With potential uses to spot lung cancers at an early stage--a holy grail of biomarker research--a nanopore sensor Read more...
NIH awards $500,000 to various miRNA biomarker studies
GenomeWeb updates us on a few biomarker projects that have attracted the attention, and funding, of the National Institutes of Health, which gave them a combined total of about $500,000. They all Read more...
New technique makes it easier to detect miRNA biomarkers
Short segments of RNA, called microRNAs (or miRNAs), are potential biomarkers for certain diseases. But it is not cheap or easy to detect these tiny strands in blood samples. So, MIT chemical Read more...
MicroRNAs are potential biomarkers for heart disease, cancer
Researchers are working on better biomarkers to detect heart disease and cancer, the number-one and number-two killers in developed countries. Chris Hebel, of genomics and proteomics company LC Read more...
Exiqon, NYU partner on miRNA for melanoma biomarkers
Those who are diagnosed with metastatic melanoma have few options. Traditional chemotherapy usually does not cure it. So, here is where the study of biomarkers can really do some good. For starters, Read more...
